David H. Kirske
Equibles does not estimate personal net worth.
Get an email with a short summary when X4 Pharmaceuticals, Inc publishes a filing, an earnings call transcript or a press release.
Get XFOR alertsAbout David H. Kirske
David H. Kirske is recorded as CFO at X4 Pharmaceuticals, Inc (XFOR) since August 12, 2025. X4 Pharmaceuticals, Inc reported in an 8-K filed August 12, 2025 that David H. Kirske was appointed Chief Financial Officer, Secretary and “principal financial officer” and “principal accounting officer”, effective August 12, 2025. X4 Pharmaceuticals, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at X4 Pharmaceuticals, Inc includes Adam Raymond Craig, M.D., Ph.D. (CEO, Chairman and Board Member), Michael Gray (CEO), Paula Ragan (CEO) and 7 others.
“in connection with the CFO Separation, on August 11, 2025, David H. Kirske was appointed as Chief Financial Officer, Secretary and “principal financial officer” and “principal accounting officer” of the Company for purposes of Section 16 of the Exchange Act, effective as of the Effective Time.”
Affiliation history
-
Current
2025-08-12–present
Company network
Leadership on record at X4 Pharmaceuticals, Inc
- Adam Raymond Craig, M.D., Ph.D. CEO, Chairman, Board Member
- Michael Gray CEO
- Paula Ragan CEO
- Adam Craig Chairman
- Adam R. Craig Chairman
- Dr. Craig Chairman, Board Member
- David Kirske CFO
- Mr. Kirske CFO
- John Volpone COO
- Mary DiBiase, Ph.D. COO